Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/21/2022 | $15.00 | Outperform | Northland Capital |
SC 13G - Oaktree Acquisition Corp. II (0001820931) (Subject)
SC 13G/A - Oaktree Acquisition Corp. II (0001820931) (Subject)
SC 13G - Oaktree Acquisition Corp. II (0001820931) (Subject)
BrandywineGLOBAL – Global Income Opportunities Fund Inc. ("BWG") Clarion Partners Real Estate Income Fund Inc. ("CPREIF") ClearBridge Energy Midstream Opportunity Fund Inc. ("EMO") LMP Capital and Income Fund Inc. ("SCD") Western Asset Diversified Income Fund ("WDI") Western Asset Emerging Markets Debt Fund Inc. ("EMD") Western Asset Global Corporate Opportunity Fund Inc. ("GDO") Western Asset Global High Income Fund Inc. ("EHI") Western Asset High Income Fund II Inc. ("HIX") Western Asset High Income Opportunity Fund Inc. ("HIO") Western Asset High Yield Defined Opportunity Fund Inc. ("HYI") Western Asset Intermediate Muni Fund Inc. ("SBI") Western Asset Investment
BrandywineGLOBAL – Global Income Opportunities Fund Inc. ("BWG") Clarion Partners Real Estate Income Fund Inc. ("CPREIF") ClearBridge Energy Midstream Opportunity Fund Inc. ("EMO") LMP Capital and Income Fund Inc. ("SCD") Western Asset Diversified Income Fund ("WDI") Western Asset Emerging Markets Debt Fund Inc. ("EMD") Western Asset Global Corporate Opportunity Fund Inc. ("GDO") Western Asset Global High Income Fund Inc. ("EHI") Western Asset High Income Fund II Inc. ("HIX") Western Asset High Income Opportunity Fund Inc. ("HIO") Western Asset High Yield Defined Opportunity Fund Inc. ("HYI") Western Asset Intermediate Muni Fund Inc. ("SBI") Western Asset Investment
Business Combination anticipated to close on or about June 15, 2022 Ordinary shares of Alvotech expected to trade under the new ticker symbol "ALVO" from June 16, 2022 on The Nasdaq Stock Market in New York and from June 23, 2022 on the Nasdaq First North Growth Market in Iceland Warrants expected to trade on The Nasdaq Stock Market in New York under the new ticker symbol "ALVOW" Alvotech Holdings S.A. ("Alvotech S.A."), a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, and Oaktree Acquisition Corp. II ("OACB") (NYSE:OACB), a special purpose acquisition company sponsored by an affiliate of Oaktree Capital Man
Business Combination remains subject to satisfaction of customary closing conditions, including shareholder approval Oaktree Acquisition Corp. II (NYSE:OACB) ("OACB" or the "Company") announced today that, assuming satisfaction of the conditions to the closing of its pending business combination with Alvotech Holdings S.A. and Alvotech ("Topco") (the "Business Combination"), including approval of the Business Combination by the Company's shareholders, Topco, as the surviving entity, intends to list its ordinary shares on The Nasdaq Stock Market LLC and the Nasdaq First North Growth Market (together "Nasdaq") under the new ticker symbol "ALVO" and its warrants on The Nasdaq Stock Market LLC
3/A - Oaktree Acquisition Corp. II (0001820931) (Issuer)
25 - Oaktree Acquisition Corp. II (0001820931) (Filer)
8-K - Oaktree Acquisition Corp. II (0001820931) (Filer)
8-K - Oaktree Acquisition Corp. II (0001820931) (Filer)
Northland Capital initiated coverage of Oaktree Acquisition Corp. II with a rating of Outperform and set a new price target of $15.00